KB Financial Group (NYSE: KB, KRX: 105560) is the largest financial holding company in South Korea by total assets (~₩758 trillion / ~$549B USD). The group operates across seven segments: Corporate Banking, Retail Banking, Other Banking (Kookmin Bank — the flagship subsidiary, largest commercial bank in Korea), Securities (KB Securities), Non-Life Insurance (KB Insurance), Credit Card (KB Kookmin Card), and Life Insurance. Headquartered in Seoul; ADR trades 1:1 with Korean ordinary shares.
Reports financials in South Korean Won (KRW); this report shows financial-statement tables in KRW (the reporting currency) and runs the DCF in USD. FX assumption: 1 USD ≈ 1,380 KRW. FY2025 net income: ₩5.85T = ~$4.24B USD. EPS: ₩15,437 = ~$11.19 USD per ADR.
The investment narrative: KB is a mature, well-capitalized Korean bank trading at 0.76x book value — a discount that reflects (1) chronic Korean banking-sector valuation suppression vs Western peers, (2) modest ROE of ~9.5%, and (3) limited US institutional coverage. Q1 2026 earnings beat market expectations by 8% on net interest margin expansion and improved cost-to-income ratio (39.3% — best in industry). Capital adequacy ratios are described by management as "industry-leading" and support an aggressive shareholder return program (dividends + buybacks running at ~7-8% of market cap annually). The stock has rerated from ~$65 in early 2025 to $110.89 today (+71%) as the "Value-Up" reform agenda in Korea has begun pulling forward valuation multiples.
Investment Thesis
KB is a low-volatility, high-yield Korean bank ADR with a credible ROE expansion trajectory and improving capital return policy. At 0.76x book and 8x earnings, the valuation has rerated meaningfully but still leaves room toward 1.0x book if Korean Value-Up reforms continue to drive corporate governance improvements.
Bull drivers: Q1 2026 was a clean beat — non-interest income +28%, cost-to-income ratio improved 400 bps. Per Seeking Alpha (Apr 24), KB has multiple ROE accretion levers: NIM expansion, funding cost optimization, international growth, and treasury share cancellation. Korean Value-Up corporate governance reforms support multiple expansion across the sector. P/B target of 1.0x = $145+ implies +30% upside before any earnings growth.
Key risks: Korean Won exposure for ADR holders — a strengthening USD compresses USD-translated dividends. P/B of 0.76x has been "cheap" for a decade — there's no guarantee the Value-Up reform agenda actually delivers multiple expansion (similar reforms in Japan took 10+ years to fully play out). Q1 2026 EPS beat depended on capital markets activity that may not repeat. Korean economy is exposed to China trade slowdown, US tariffs, and Won/USD volatility.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total Revenue | ₩21.0T | ₩25.6T | ₩36.4T | ₩37.8T | ₩50.7T |
| Net Interest Income | ₩11.2T | ₩11.6T | ₩12.2T | ₩12.8T | ₩16.1T |
| NII Growth | — | +2.9% | +5.5% | +5.3% | +25.4% |
| Operating Income | ₩6.08T | ₩5.39T | ₩6.12T | ₩6.99T | ₩8.53T |
| Operating Margin | 29.0% | 21.0% | 16.8% | 18.5% | 16.8% |
| Net Income | ₩4.41T | ₩4.11T | ₩4.59T | ₩5.08T | ₩5.85T |
| EPS (Diluted, KRW) | ₩10,889 | ₩10,099 | ₩11,217 | ₩12,725 | ₩15,287 |
| EPS Growth | — | -7.3% | +11.1% | +13.4% | +20.1% |
| Metric | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Total Assets | ₩655.7T | ₩688.7T | ₩715.7T | ₩757.8T |
| Cash & ST Investments | ₩92.1T | ₩112.0T | ₩113.3T | ₩124.7T |
| Long-Term Investments | ₩537.9T | ₩549.4T | ₩570.0T | ₩602.7T |
| Total Deposits + Liab. | ₩606.3T | ₩634.9T | ₩657.1T | ₩698.0T |
| Total Debt (LT + ST) | ₩139.3T | ₩152.8T | ₩137.0T | ₩140.8T |
| Stockholders' Equity | ₩48.5T | ₩52.5T | ₩56.7T | ₩57.9T |
| Tangible Book Value | ₩47.6T | ₩51.9T | ₩56.7T | ₩57.9T |
| Shares Outstanding (M) | 390 | 390 | 384 | 379 |
| Book Value per Share (KRW) | ₩124,560 | ₩134,801 | ₩147,626 | ₩152,836 |
| Metric | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Operating Cash Flow | -₩2.0T | ₩4.76T | ₩4.11T | ₩4.02T |
| Capital Expenditures | -₩478B | -₩497B | -₩680B | -₩627B |
| Free Cash Flow | -₩2.5T | ₩4.26T | ₩3.43T | ₩3.39T |
| Dividends Paid | -₩982B | -₩1.44T | -₩1.15T | -₩1.49T |
| Share Buybacks | ₩0 | ₩0 | -₩572B | -₩820B |
| Total Capital Returns | -₩982B | -₩1.44T | -₩1.72T | -₩2.31T |
| Multiple | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| P/E Ratio | 4.9x | 4.6x | 4.5x | 6.3x | 8.0x |
| P/B Ratio | 0.44x | 0.36x | 0.36x | 0.55x | 0.76x |
| Dividend Yield | 4.59% | 7.59% | 5.61% | 4.68% | 2.92% |
| P/S Ratio | 1.02x | 0.74x | 0.56x | 0.84x | 0.93x |
| P/FCF Ratio | N/M | 4.4x | 6.0x | 9.4x | N/A |
| EV/EBITDA | 18.2x | 22.2x | 18.2x | 17.9x | 5.5x |
| Payout Ratio | 22.3% | 35.0% | 25.1% | 29.3% | 23.4% |
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Return on Equity | 9.1% | 7.8% | 8.1% | 8.8% | 9.5% |
| Return on Assets | 0.67% | 0.60% | 0.64% | 0.67% | 0.77% |
| Cost-to-Income (Op Mgn) | 71.0% | 79.0% | 83.2% | 81.5% | 83.2% |
| Net Margin | 21.0% | 16.0% | 12.6% | 13.4% | 11.5% |
| Effective Tax Rate | 27.9% | 27.9% | 26.0% | 28.0% | 28.6% |
| Metric | FY2025A | FY2026E | FY2027E | FY2028E |
|---|---|---|---|---|
| Revenue (Avg, KRW) | ₩50.69T | ₩19.30T* | ₩19.87T* | ₩20.42T* |
| EPS (Avg, KRW) | ₩15,287 | ₩18,115 | ₩19,503 | ₩20,971 |
| EPS Growth | +20.1% | +18.5% | +7.7% | +7.5% |
| EPS (USD, ADR) | $11.08 | $13.13 | $14.13 | $15.20 |
| # Analysts | 15 Rev / 1 EPS | 15 / 1 | 16 / 1 | 14 / 1 |
| Fwd P/E (USD price / USD EPS) | 10.0x | 8.4x | 7.8x | 7.3x |
| Name | Title | Type | Shares | Price | Date |
|---|---|---|---|---|---|
| FMP returned no insider transactions for KB. Korean ADR insiders typically file via KRX (Korea Exchange) rather than EDGAR. The DART (Korean equivalent of EDGAR) at dart.fss.or.kr is the authoritative source for KB insider activity. | |||||
Korean Value-Up reform agenda is finally pulling forward valuations. KB has rerated from 0.36x book to 0.76x book over 12 months. Target zone for top-tier Korean bank franchises is 1.0-1.2x book, implying $145-175 stock price (+30-58% upside) before any further earnings growth.
Q1 2026 was a clean operational beat. NII +28%, cost-to-income at 39.3% (best-in-class), ROE expanding to ~12% per Seeking Alpha (Apr 24). Multiple ROE accretion levers remain: NIM expansion, funding cost optimization, international growth, treasury share cancellation.
Capital return policy is accelerating. Total returned to shareholders grew from ₩982B (FY21) to ₩2.31T (FY24). Buyback program ramped from ₩0 to ₩820B annually. Implied 5%+ annual capital return at current market cap. KB's "industry-leading capital adequacy" supports continued aggressive buyback expansion.
Beta of 0.76 is rare for an EM bank ADR. Provides portfolio diversification with mid-cycle ROE exposure. Mid-7% earnings yield + 2.9% dividend yield = ~10% expected return even before any P/B rerating.
Zacks Strong Buy upgrade (Feb 17, 2026) reflects momentum. Consensus EPS estimates have been revised higher 4 of 5 quarters per recent earnings cycle.
Korean banks have been "cheap" for a decade. The "Value-Up" rerating thesis is plausible but unproven — similar reforms in Japan (which inspired Korea's program) took 10+ years to fully play out. If reforms stall or implementation disappoints, the stock could re-derate to 0.5-0.6x book (=$70-85, -23% to -37%).
Stock has rerated 70% in 12 months, leaving little margin of safety. 84% of 52-week range, 50-DMA already +5% above current — momentum-driven flows are vulnerable to any sentiment shift. The Feb 2026 Benzinga "Top 3 Financial Stocks You May Want To Dump" piece flagged KB on momentum-derisking grounds.
Q1 2026 earnings beat depended on capital markets revenue (+28% non-interest income). Capital markets activity is volatile and may not repeat. Underlying NII trajectory is more modest at +5-7% historical.
FX risk for ADR holders. 1Y USD/KRW chart shows ~10% Won appreciation through 2025. If USD strengthens, USD-translated dividends compress; if Korean export concerns drive Won weaker, the same.
Korean economic exposure to China + US tariffs. Korea's export-heavy economy is sensitive to trade frictions. A meaningful escalation in US-China trade tensions in 2026-2027 would compress Korean bank loan growth and asset quality simultaneously.
The rerating thesis depends on Korea's corporate governance reform implementation. If KOSPI 200 inclusion criteria, Tier-1 capital expectations, or shareholder return mandates dilute, the P/B trajectory toward 1.0x may slow or reverse. Reform momentum is the single most important narrative driver.
USD-translated dividend income for ADR holders is exposed to KRW/USD. A 5% Won weakening compresses USD distributions by ~5%; KRW strength is a tailwind. Korea's central bank rate path and trade balance are the key Won drivers.
Korean property prices have been weak through 2024-2025; loan-loss provisions could rise if commercial real estate stress accelerates. KB's mortgage book is largest among Korean banks, providing both scale and concentration risk.
North Korea, US-China-Korea trade frictions, and Taiwan Strait dynamics all add tail risk to Korean equities. Rare but catastrophic; difficult to hedge specifically with KB ADR.
FMP returned no aggregated price target consensus. Last broker rating change captured in the FMP feed was 2018 (BoA Buy → Neutral). Most Korean bank coverage is local — US institutional flow is thin and the ADR can move significantly on light volume.
Korean Financial Services Commission (FSC) periodically issues capital-adequacy guidance changes. Tier-1 minimum increases or shareholder-return restrictions would directly impact buyback pace and dividend trajectory.
Korean Value-Up reforms accelerate; KB rerates to 1.0x book = ~$145 + ~10% EPS growth = $155+. ROE expands to 11-12%. Buyback program steps up to ~$1B+ annually. KRW stable to strengthening.
P/B holds at 0.80-0.85x as ROE grinds toward 10%. Consensus EPS lands near ₩18,115 ($13.13). Stable Won. Capital returns continue at current pace.
Korean Value-Up reform momentum stalls; rerating reverses to 0.55-0.60x book. Property loan-loss provisions step up. KRW weakens 8-10%. Stock rederates toward $80-90 range with the 200-DMA at $91 as support.
This report was generated using FMP financial data as of May 6, 2026. This is for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.